Sentence examples for shows cost effectiveness from inspiring English sources

If vaccine induced immunity lasts on average around 20 years then about 25-85% of scenarios suggest that the vaccination programme is cost effective (fig 1). Figure 1 also shows cost effectiveness acceptability curves resulting from the use of more optimistic assumptions.

Table 5 shows cost effectiveness results for the base case analysis.

Table 6 shows cost effectiveness for the total population of remediation in areas with a mean indoor radon concentration of 60 Bq/m and with an action level of 100 Bq/m for a household of average size.

The QALY gains from preventing these infections are smaller because these human papillomavirus types account for a minority (about 30%) of cervical cancers in the UK. Figure 1 shows cost effectiveness acceptability curves for this vaccination programme, given different assumptions about the duration of protection from the vaccine.

Psychosocial treatments for alcohol disorders have shown cost effectiveness in a large, randomized study of different treatments in the United Kingdom.

Evaluations showed cost effectiveness in life years gained (50), and the need for health professionals to be aware of an individual's willingness or potential to achieve suggested lifestyle changes (51).

Figure 4, shows cost-effectiveness of patients treated under community DOT and health facility based DOT.

Based on GDP per capita in each province and baseline of transition probability parameters, universal strategy shows cost-effectiveness in Guangdong, Shandong, and Beijing, and targeted strategy shows cost-effectiveness in Zhejiang and Hebei, while neither of the screening strategy shows cost-effectiveness in Guangxi, Jiangxi and Henan.

Figure 3 shows cost-effectiveness acceptability curves (Fenwick et al, 2001; Fenwick et al, 2004) for ALD, HBV, HCV and the mixed cohort.

Figures  3A-C shows cost-effectiveness acceptability curves indicating the probability that the cost-effectiveness of the modified TEE strategy would be acceptable for various cost-effectiveness threshold (CET) values [ 47].

In this trial in a population of patients with advanced NSCLC considered unfit for first-line chemotherapy, erlotinib did not show cost-effectiveness overall, however, it has potential for being cost-effective in patients who develop first cycle rash.